News

Find News

Filter articles

Applied Filters

Showing 81 to 90 of 225 results

Mylan enters MPP agreement over affordable hepatitis C generics

International29-11-2016

Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool, a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries.

Sun Pharma acquires Biosintez

India, Russia24-11-2016

India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez.

Sanofi and Genzyme recover domain at WIPO

International16-11-2016

Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.

GSK triumphs in trademark suit in India

India09-11-2016

Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India.

Sun Pharma to acquire Ocular Technologies for $40m

India03-11-2016

India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million.

Astellas to acquire Ganymed for €422m

Germany, Japan31-10-2016

Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.

Sunovion Pharmaceuticals acquires Cynapsus for $653m

Canada, Japan, US26-10-2016

Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.

Novartis wins growth hormone domain dispute

International20-10-2016

Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center.

Sun Pharma collaborates with ICGEB to develop dengue vaccine

India19-10-2016

Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets.

Janssen sells five drugs for $155m

India12-10-2016

India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash.

Showing 81 to 90 of 225 results

LSIPR